Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper

O Pfaar; K Bastl; U Berger; J Buters; MA Calderon; B Clot; U Darsow; P Demoly; SR Durham; C Galan; R Gehrig; Roy Gerth van Wijk; L Jacobsen; L Klimek; M Sofiev; M Thibaudon; KC Bergmann

doi:10.1111/all.13092

Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper

O Pfaar, K Bastl, U Berger, J Buters, MA Calderon, B Clot, U Darsow, P Demoly, SR Durham, C Galan, R Gehrig, Roy Gerth van Wijk, L Jacobsen, L Klimek, M Sofiev, M Thibaudon, KC Bergmann

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

164 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	713-722
Number of pages	10
Journal	Allergy
Volume	72
Issue number	5
DOIs	https://doi.org/10.1111/all.13092
Publication status	Published - 2017

Research programs

EMC OR-01

Access to Document

10.1111/all.13092

http://hdl.handle.net/1765/97709

Cite this

Pfaar, O., Bastl, K., Berger, U., Buters, J., Calderon, MA., Clot, B., Darsow, U., Demoly, P., Durham, SR., Galan, C., Gehrig, R., Gerth van Wijk, R., Jacobsen, L., Klimek, L., Sofiev, M., Thibaudon, M., & Bergmann, KC. (2017). Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper. Allergy, 72(5), 713-722. https://doi.org/10.1111/all.13092

@article{26f1b85ff4d4471f88ddeade00fa7697,

title = "Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper",

author = "O Pfaar and K Bastl and U Berger and J Buters and MA Calderon and B Clot and U Darsow and P Demoly and SR Durham and C Galan and R Gehrig and \{Gerth van Wijk\}, Roy and L Jacobsen and L Klimek and M Sofiev and M Thibaudon and KC Bergmann",

year = "2017",

doi = "10.1111/all.13092",

language = "Undefined/Unknown",

volume = "72",

pages = "713--722",

journal = "Allergy",

issn = "0105-4538",

publisher = "Wiley-Blackwell Publishing Ltd",

number = "5",

}

Pfaar, O, Bastl, K, Berger, U, Buters, J, Calderon, MA, Clot, B, Darsow, U, Demoly, P, Durham, SR, Galan, C, Gehrig, R, Gerth van Wijk, R, Jacobsen, L, Klimek, L, Sofiev, M, Thibaudon, M & Bergmann, KC 2017, 'Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper', Allergy, vol. 72, no. 5, pp. 713-722. https://doi.org/10.1111/all.13092

TY - JOUR

T1 - Defining pollen exposure times for clinical trials of allergen immunotherapy for pollen-induced rhinoconjunctivitis - an EAACI position paper

AU - Pfaar, O

AU - Bastl, K

AU - Berger, U

AU - Buters, J

AU - Calderon, MA

AU - Clot, B

AU - Darsow, U

AU - Demoly, P

AU - Durham, SR

AU - Galan, C

AU - Gehrig, R

AU - Gerth van Wijk, Roy

AU - Jacobsen, L

AU - Klimek, L

AU - Sofiev, M

AU - Thibaudon, M

AU - Bergmann, KC

PY - 2017

Y1 - 2017

U2 - 10.1111/all.13092

DO - 10.1111/all.13092

M3 - Article

C2 - 27874202

SN - 0105-4538

VL - 72

SP - 713

EP - 722

JO - Allergy

JF - Allergy

IS - 5

ER -